Vimarsana
Biggest News Aggregation in the World

Page 4 - Its Evernorth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Its Evernorth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Its Evernorth Today - Breaking & Trending Today

Cigna (NYSE:CI) Price Target Raised to $301.00 at Sanford C. Bernstein - Vimarsana News

Cigna (NYSE:CI) Price Target Raised to $301.00 at Sanford C. Bernstein

Cigna (NYSE:CI – Get Rating) had its price target raised by research analysts at Sanford C. Bernstein from $258.00 to $301.00 in a report released on Friday, Stock Target Advisor reports. The brokerage currently has a “mkt perform” rating on the health services provider’s stock. Sanford C. Bernstein’s price objective indicates a potential upside of […]

$44.34 Billion in Sales Expected for Cigna Co. (NYSE:CI) This Quarter - Vimarsana News

$44.34 Billion in Sales Expected for Cigna Co. (NYSE:CI) This Quarter

Analysts expect that Cigna Co. (NYSE:CI – Get Rating) will report $44.34 billion in sales for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Cigna’s earnings, with the highest sales estimate coming in at $45.01 billion and the lowest estimate coming in at $43.78 billion. Cigna posted sales of $43.11 […]

Barclays Boosts Cigna (NYSE:CI) Price Target to $310.00 - Vimarsana News

Barclays Boosts Cigna (NYSE:CI) Price Target to $310.00

Cigna (NYSE:CI – Get Rating) had its price objective lifted by research analysts at Barclays from $275.00 to $310.00 in a research report issued to clients and investors on Monday, The Fly reports. Barclays‘s price objective would indicate a potential upside of 19.47% from the company’s previous close. A number of other equities analysts have […]

Cigna (NYSE:CI) Stock Rating Upgraded by JPMorgan Chase & Co. - Vimarsana News

Cigna (NYSE:CI) Stock Rating Upgraded by JPMorgan Chase & Co.

Cigna (NYSE:CI – Get Rating) was upgraded by investment analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research report issued on Monday, The Fly reports. Several other equities research analysts have also commented on CI. Oppenheimer boosted their price objective on shares of Cigna from $300.00 to […]

Cigna (NYSE:CI) Upgraded to Overweight by JPMorgan Chase & Co. - Vimarsana News

Cigna (NYSE:CI) Upgraded to Overweight by JPMorgan Chase & Co.

Cigna (NYSE:CI – Get Rating) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Monday, The Fly reports. Other equities analysts have also recently issued research reports about the company. StockNews.com initiated coverage on Cigna in a research […]